Pricing

Engagements matched to your compound stage.

Choose a focused pilot for one decision or a subscription for multiple compounds. Every engagement begins with a scoping call.

Compound Pilot
$18,000 flat engagement fee

One compound, one indication, one decision. For teams assessing simulation before a broader commitment.

  • Single compound and indication
  • Up to 3 dose scenarios simulated
  • 500 virtual patient simulations per run
  • P(success) output with 90% credible intervals
  • PDF and CSV output delivery
  • 1 methodology consultation call with QuantHealth scientist
  • 3-week turnaround from signed data intake
Most selected
Program
$72,000 per year

For teams planning up to three compounds through Phase 2. Covers all simulation types, with CDISC-compatible output for regulatory documentation.

  • Up to 3 compounds per year
  • All use case types: dose, enrichment, adaptive design
  • CDISC-compatible structured output (ADaM/SDTM-aligned)
  • Quarterly model recalibration as new data arrives
  • Phase 2/3 bridge analysis outputs
  • Quarterly review sessions with dedicated scientist
  • Priority email support
Portfolio
Custom custom program

For teams comparing multiple compounds in one indication class or coordinating simulation across a pipeline.

  • 3 or more compounds, standardized comparison
  • Portfolio-level P(success) ranking
  • JSON API access for integration
  • Custom therapeutic area module development
  • All Professional tier deliverables
  • Monthly review cadence
  • Executive summary prepared for portfolio committees

Feature comparison

Feature Compound Pilot Program Portfolio
Compounds per year 1 Up to 3 4+
Dose optimization analysis
Enrichment strategy analysis
Adaptive design OC analysis
Portfolio P(success) ranking
Regulatory documentation package Basic Full Full + custom
Sensitivity analysis
JSON API access
Turnaround time 3 weeks 2-3 weeks per run Custom SLA

Pricing and engagement questions

  • The $18,000 Compound Pilot fee applies when an existing validated disease module covers your indication. Oncology, autoimmune, CNS, and metabolic disease indications are covered. A new module is scoped as a separate custom engagement before Pilot work starts. We confirm availability during the scoping call.
  • A QuantHealth scientist reviews your compound mechanism, decision, available data, and relevant disease module availability. Calls are usually 45 minutes. Within five business days, we send a written engagement proposal covering turnaround, deliverable scope, and fee range.
  • A standard Pilot or Professional engagement requires a compound mechanism summary, available PK or PKPD parameters from preclinical through Phase 1, and the protocol outline under consideration. Patient-level raw data, a full dossier, and data beyond pre-IND or early Phase 2 planning are not needed. Bring uncertainties to the scoping call for assessment.
  • QuantHealth provides decision support tools, not validated regulatory models, and does not submit them directly to agencies. Program and Portfolio deliverables include methodology documentation designed for clarity in a regulatory briefing context, including a Type B or C meeting. Teams use the analysis as supporting material, not primary evidence. Each methodology document explains appropriate use.
  • A Pilot takes about 3 weeks from signed data intake to first draft. Program work generally takes 2-3 weeks per run. Portfolio work follows a custom SLA based on compounds and modules. A new disease module adds 2-4 weeks for validation.
  • Yes. The compound context and disease module carry forward, with no intake restart. On request, the Pilot fee is applied to the first quarter of the Professional program.
Start here

Start with one compound, one decision.

Book a 45-minute scoping call to see whether simulation can clarify P(success) before you commit.